ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
10,013,893
Share change
+648,015
Total reported value
$7,847,971
Put/Call ratio
0%
Price per share
$0.78
Number of holders
53
Value change
+$474,820
Number of buys
15
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q1 2023

As of 31 Mar 2023, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,013,893 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BIT Capital GmbH, KENNEDY CAPITAL MANAGEMENT LLC, Quantum Private Wealth, LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIGHTON JONES LLC, RENAISSANCE TECHNOLOGIES LLC, and LPL Financial LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.